Hyperpolarization Platform for MRI Wins EU Innovation Award

By News Release

The winner of the European Commission’s 2022 Innovation Radar Prize is NVision Imaging Technologies from Germany, a quantum tech company founded by world-leading spin-physics experts. The company has developed a hyperpolarization platform which enhances the MRI signal of natural metabolites, enabling these safe molecules to be used as agents for imaging tumor metabolism via standard MRIs. This safe imaging technology will provide oncologists unprecedented early insights into treatment efficacy at the metabolic level, allowing non-responders to be moved onto another line of therapy more quickly. NVision received EU funding via the MetaboliQs project.

From over 300 applicants, a longlist was put to a public vote which resulted in a shortlist of 12 finalists. The 12 finalists for the three categories pitched in front of the Jury panel comprised of investors at an online event co-organized by the Dealflow.eu consortium on 15 November 2022. The overall Innovation Radar Prize Winner will be featured in a special Euronews broadcast later this year.

NVision, a quantum tech company founded by world-leading spin-physics experts, has developed a hyperpolarization platform which enhances the MRI signal of natural metabolites, enabling these safe molecules to be used as agents for imaging tumor metabolism via standard MRIs. This safe imaging technology will provide oncologists unprecedented early insights into treatment efficacy at the metabolic level, allowing non-responders to be moved onto another line of therapy more quickly. NVision received EU funding via the MetaboliQs project.

Back To Top

Hyperpolarization Platform for MRI Wins EU Innovation Award.  Appl Radiol. 

By News Release| November 18, 2022

About the Author

News Release

News Release

Copyright © Anderson Publishing 2022